The page is the record's research on the issuer — no analyst, no rating, no view. # agilon health, inc. (NYSE: AGL) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is agilon health, inc., listed on the NYSE under ticker AGL, with ISIN US00857U2069. Its LEI is not on the record, because no GLEIF record with the exact legal name in jurisdiction US-DE was found. Its security type is Corporate, its sector is 8090 Services-Misc Health & Allied Services, NEC, and its jurisdiction is the United States, Delaware. Its segment is not on the record. Its status is listed, not halted. ## The disclosure read The record holds 56 filings in the twelve months to 2026-11-08, across 34 filing days. The filings by type are: 1 ad hoc, 8 AGM/EGM, 1 corporate news, 3 director changes, 28 directors' dealings, 7 regulatory filings, and 8 results. The median gap between filing days is 6 days. The latest filing is dated 2026-11-04 and is of type results, 4 days before the record date. The NYSE median cadence gap is 6.0 days, with a median of 64.0 filings and a median latency of 4.0 days across 3,256 issuers. The sector median cadence gap is 6.0 days, with a median of 56 filings and a median latency of 5 days across 13 issuers. The issuer's 56 filings equal the sector median of 56 and sit below the NYSE median of 64.0. ## Auditor The auditor of record is Ernst & Young LLP, located in Los Angeles, California. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001831097.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NYSE/AGL (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1831097/000162828026011655/agl-20251231.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NYSE/AGL (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/AGL · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp